The CEO Sessions

An opportunity for investors and advisers to hear directly from listed company CEOs on company strategy, prospects, and performance.

ASX and FNN are proud to present a program of forums for investors. Hear CEOs and senior representatives of listed companies present their investment story.
Join them afterwards for an informal meet and greet session, with lunch provided.


Register your attendance for an upcoming event

Upcoming Events in Sydney

16 May 2017

James-Garner
Novogen Limited (ASX:NRT)
Dr. James Garner, CEO

Novogen (ASX:NRT, NASDAQ:NVGN) is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Novogen collaborates with leading scientists, clinicians, and investors around the world.
 
Anthony-McClure
Silver Mines Limited (ASX:SVL)
Anthony McClure, Managing Director

Silver Mines Limited is an Australian public resource company listed on the Australian Securities Exchange.
The Company has recently purchased the Bowdens Silver Project located near Mudgee in New South Wales. The Project holds substantial resources as the largest undeveloped silver project in Australia and one of the largest globally.
The recently consolidated Project area comprises 1,654 sqaure kilometres (408,000 acres) of titles covering approximately 80 kilometres of strike of the highly mineralsied Rylstone Volcanics.
 
Megan-Baldwin
Opthea Limited (ASX:OPT)
Dr. Megan Baldwin, Managing Director and CEO

Opthea controls exclusive worldwide rights to a significant intellectual property portfolio around Vascular Endothelial Growth Factor (VEGF)-C, VEGF-D and VEGF receptor-3 (VEGFR-3).
Their lead molecule is a soluble form of VEGFR-3, OPT-302 (formerly VGX-300), that acts as a VEGF-C/VEGF-D ‘trap’. The molecule blocks blood and lymphatic vessel growth and inhibits vascular leakage. OPT-302 is initially being developed for the treatment of neovascular (‘wet’) age-related macular degeneration (wet AMD), the leading cause of blindness in the Western world, with the potential to expand their development program for other eye diseases.
 
Ron-Heeks
Geopacific Resources Limited (ASX:GPR)
Ron Heeks, Managing Director

Geopacific Resources Limited (ASX: GPR) is a gold-copper development company with a portfolio of assets in the Asia-Pacific region and sights set firmly on production.
The experienced team at Geopacific is developing the fully permitted, 2.1 million ounce Woodlark Gold Project situated on an Island in Papua New Guinea.
Geopacific’s other gold and copper-gold projects cover the spectrum from early to advanced exploration and are situated in Cambodia and Fiji.
 
Jarrod Ritchie
Global Geoscience Limited (ASX:GSC)
Bernard Rowe, Managing Director

Global Geoscience (ASX:GSC) is a Sydney based exploration company with a strategic, advanced Lithium-Boron project located in the USA. The Rhyolite Ridge deposit contains a Resource of 3.4 million tonnes of lithium carbonate. The project is located close to existing infrastructure in the mining-friendly state of Nevada and has excellent potential to expand and rapidly advance.
  • Strategic location: stable, mining friendly jurisdiction and close to existing infrastructure
  • Advanced project: Resource stage with over 100 drill holes, moving into pre-feasibility in early 2017
  • Large and scaleable: 393Mt Resource with potential to become a major, low-cost supplier to support the rising global demand for lithium carbonate.

 

Dexus at The CEO Sessions

Crowd at The CEO Sessions

Investor Audience at The CEO Sessions